Brenda Mann - 03 Aug 2021 Form 4 Insider Report for EYEGATE PHARMACEUTICALS INC (KPRX)

Role
VP of Research & Development
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Issuer symbol
KPRX
Transactions as of
03 Aug 2021
Net transactions value
-$151
Form type
4
Filing time
04 Aug 2021, 17:45:54 UTC
Previous filing
06 Jul 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability $151 -63 -0.41% $2.40 15,321 03 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021.